Tokyo, Japan

Rei Matsueda

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rei Matsueda. Retrieved from https://idiyas.com/inventor/rei-matsueda-hzs6lu99

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rei Matsueda: Innovator in Peptide Research

Introduction

Rei Matsueda is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of peptide research, particularly in the development of cysteine-containing peptides. Her innovative work has the potential to impact various pharmaceutical applications.

Latest Patents

Matsueda holds a patent for "Cysteine (NPYS)-containing peptides and use thereof for inhibiting." This patent includes peptides and pharmaceutically acceptable salts of a specific formula, wherein R is selected from the group consisting of Leu, Ile, and Val. This invention showcases her expertise in biochemistry and its applications in medicine.

Career Highlights

Throughout her career, Rei Matsueda has demonstrated a strong commitment to advancing scientific knowledge in her field. Her work has not only led to the development of innovative peptides but has also opened new avenues for research and application in pharmaceuticals.

Collaborations

Matsueda has collaborated with notable professionals in her field, including Robert W. Colman and Rajinder N. Puri. These collaborations have enriched her research and contributed to the success of her innovative projects.

Conclusion

Rei Matsueda is a trailblazer in peptide research, with a focus on cysteine-containing peptides. Her contributions to the field are noteworthy, and her patent reflects her dedication to advancing pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…